CG Oncology’s Executive Leadership to Participate in Upcoming Investor Conferences
(NASDAQ:CGON) IRVINE, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a poten...
1 day ago